DENTSPLY SIRONA Director Brian Gladden Receives 22,822 Restricted Stock Units

This SEC Form 4 filing reports that Brian T. Gladden, a director of DENTSPLY SIRONA Inc. (XRAY), received 22,822 restricted stock units (RSUs) on June 3, 2026. The RSUs were granted at $0 per share and consist entirely of equity awards that vest in full one year from the grant date. Following this transaction, Gladden's total holdings in DENTSPLY SIRONA common stock increased to 51,863.522 shares. The filing indicates this is a director-level transaction (Gladden is listed as a director but not an officer) and represents an equity compensation award rather than a market purchase. The transaction was filed on June 5, 2026, with Jessica Nielsen Causey acting as attorney-in-fact for Brian T. Gladden.